RA

Rosalind Advisors Portfolio holdings

AUM $207M
This Quarter Return
+19.06%
1 Year Return
+62.29%
3 Year Return
5 Year Return
10 Year Return
AUM
$151M
AUM Growth
+$151M
Cap. Flow
-$156M
Cap. Flow %
-103.79%
Top 10 Hldgs %
73%
Holding
44
New
3
Increased
10
Reduced
11
Closed
9

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
DERM icon
26
Journey Medical
DERM
$169M
$598K 0.38%
105,917
-8,215
-7% -$46.4K
NAMS icon
27
NewAmsterdam Pharma
NAMS
$2.8B
$168K 0.11%
10,123
CLSD icon
28
Clearside Biomedical
CLSD
$26.7M
$162K 0.1%
127,220
-2,465,373
-95% -$3.13M
VOR icon
29
Vor Biopharma
VOR
$253M
$53.7K 0.03%
+76,685
New +$53.7K
ALNY icon
30
Alnylam Pharmaceuticals
ALNY
$58.6B
0
ANVS icon
31
Annovis Bio
ANVS
$44.4M
0
BTAI icon
32
BioXcel Therapeutics
BTAI
$52.7M
-39,672
Closed -$50.8K
GERN icon
33
Geron
GERN
$893M
-200,000
Closed -$848K
LYRA icon
34
Lyra Therapeutics
LYRA
$11.8M
-1,034,773
Closed -$286K
QQQ icon
35
Invesco QQQ Trust
QQQ
$364B
0
RZLT icon
36
Rezolute
RZLT
$630M
-250,000
Closed -$1.08M
SAVA icon
37
Cassava Sciences
SAVA
$107M
0
TNXP icon
38
Tonix Pharmaceuticals
TNXP
$243M
-28,154
Closed -$19.6K
UNCY icon
39
Unicycive Therapeutics
UNCY
$75.8M
-1,571,200
Closed -$787K
VRDN icon
40
Viridian Therapeutics
VRDN
$1.59B
-300,000
Closed -$3.9M
XAIR icon
41
Beyond Air
XAIR
$12.1M
-903,614
Closed -$486K
XBI icon
42
SPDR S&P Biotech ETF
XBI
$5.29B
0
SPRB
43
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
-1,508,419
Closed -$781K
GTHX
44
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
0